Ozempic for weight loss is disrupting companies’ business model

  • 📰 mercnews
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 68%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Companies from Walmart Inc. to Conagra Brands Inc. are weighing how much to factor the diabetes drugs known as GLP-1s, increasingly being used for weight loss, into their strategies.

“Companies will overreact. The smart money will take action, but act slowly,” said Gary Stibel, chief executive officer of New England Consulting Group, which advises consumer and health care companies.

He recalled the olestra fad of the 1990s, when the fat substitute rapidly invaded the food aisle before being discarded due to its unpleasant side effects. “We’ve lived through what I think turned out to be a fad that we predicted would be a fad,” Richard Rosenfield, then an executive at California Pizza Kitchen, said in 2005. “It never seemed to affect our business. We did great through that craze.”

Even so, recent findings are eye-opening. A survey of GLP-1 users by Jefferies showed that more than 40% of respondents said they were eating out less. A similar percentage reported ordering less when they did. About 70% said they’re eating less overall, and roughly the same amount reported “increased awareness of nutritional benefits for foods.”

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 88. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Dialysis-company stocks slide after Ozempic trial's success in treating kidney diseaseDaVita’s stock was down 16%, while Baxter and Intuitive Surgical were down 9% and 6%
출처: MarketWatch - 🏆 3. / 97 더 많은 것을 읽으십시오 »

Stocks edge higher, 10-year auction on deck, Ozempic trial success, Exxon-Pioneer takeover, Delta Air...Stocks higher, 10-year auction, Ozempic, Exxon-Pioneer, Delta Air Lines
출처: startelegram - 🏆 248. / 63 더 많은 것을 읽으십시오 »